Progress Toward Expanded Adult Smoke-Free Nicotine Access

The U.S. Food & Drug Administration (FDA) Has Made Improvements

The FDA’s Center for Tobacco Products (CTP) was created to reduce the serious health harms caused by smoking. For over a decade, the process of reviewing new smoke-free nicotine products has moved slowly – leaving millions of American adults who smoke without access to better alternatives.

That’s starting to change.

Here’s What’s Happening

New Leadership Makes a Difference

The Trump Administration brought in new leadership to focus on science-based decisions and more efficient processes. This leadership change has shown some results in the agency’s review of applications for select smoke-free nicotine products.

A Smarter Review Process

The FDA established a nicotine pouch product pilot program to review applications more efficiently – without cutting corners on risk level or science. This streamlined approach will review and authorize new products faster, while maintaining scientific standards.

The Results Will Speak for Themselves

Improvements can mean faster decisions, more FDA-authorized options for adults who smoke and real progress toward the FDA’s original mission: reducing the harms of smoking.

Why This Matters

Smoking is America’s Number One Preventable Health

Cigarette smoking costs our country more than $300 billion per year in healthcare costs and remains the leading cause of preventable death and disease.

Science Shows Progress

Research published in peer-reviewed journals shows that smoke-free nicotine products can help adults move away from cigarettes. Other countries, such as Japan, have successfully reduced smoking rates by supporting these products.

Doctors Need Better Information

Many healthcare providers don’t have current, accurate information about smoke-free nicotine products. When doctors understand the facts – that it’s the toxic chemicals in tobacco smoke, not nicotine itself, that cause serious health problems – they can better counsel adult patients who smoke about their options.

Adults Deserve Accurate Information

People who are misinformed about nicotine are less likely to switch away from cigarettes. Getting accurate information to healthcare providers and their adult patients who smoke is essential.

Moving Forward

The recent improvements at the FDA will show that smarter, more efficient government processes can deliver real health benefits. These changes must continue so that the 30 million American adults who smoke have access to a wider range of authorized smoke-free nicotine products that could help them transition away from cigarettes.

Progress is possible. The FDA can prove it.

Tell Congress: Keep Progress Moving!

Support smoke-free nicotine reform. Send a letter NOW!